عرض بسيط للتسجيلة

المؤلفAl Taher, F. T.
المؤلفAfifi, N. A.
المؤلفHassan, N. S.
المؤلفAsker, B. A.
المؤلفHabboub, L.
تاريخ الإتاحة2022-03-17T07:41:32Z
تاريخ النشر2008
اسم المنشورQatar Medical Journal
المصدرqscience
الاقتباسAl Taher, F. T.; Afifi, N. A.; Hassan, N. S.; Asker, B. A.; Habboub, L. Evaluation of the Universal Screening Strategy in Qatar for the Management of Pregnant Women Carrying Group B Streptococci, Qatar Medical Journal, Volume 2008, Issue 1,pp 10-13 https://doi.org/10.5339/qmj.2008.1.8
الرقم المعياري الدولي للكتاب0253-8253
الرقم المعياري الدولي للكتاب2227-0426
معرّف المصادر الموحدhttps://doi.org/10.5339/qmj.2008.1.8
معرّف المصادر الموحدhttp://hdl.handle.net/10576/28270
الملخصGroup B Streptococcus infection (GBS) has emerged as a serious disease, infecting 18,000 people in the United States annually including life-threatening illness in about 8,000 newly-born infants. To evaluate the efficiency of the current universal screening strategy for the management of GBS carriers a retrospective analysis was made of the records of 1,620 pregnant women in Qatar, 550 of whom were found to be carriers. These latter were then used as a group to be compared with 450 uninfected pregnant women in terms of nationality, parity, age, treatment, and outcome. Young and nullipara pregnant women had a high incidence of GBS but there was no significant effect on birth mortality and morbidity regardless of whether or not they received treatment with antibiotics. It is suggested that the cost of screening for GBS at the 35 th week of gestation cannot be justified.
اللغةen
الناشرHamad bin Khalifa University Press (HBKU Press)
الموضوعGroup B Streptococci
Pregnancy
Qatar
العنوانEvaluation of the Universal Screening Strategy in Qatar for the Management of Pregnant Women Carrying Group B Streptococci
النوعArticle
رقم العدد1
رقم المجلد2008
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة